These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6714295)

  • 1. Pharmacokinetics of enprofylline in patients with impaired renal function after a single intravenous dose.
    Lunell E; Borgå O; Larsson R
    Eur J Clin Pharmacol; 1984; 26(1):87-93. PubMed ID: 6714295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enprofylline kinetics in healthy subjects after single doses.
    Borgå O; Andersson KE; Edholm LE; Fagerström PO; Lunell E; Persson CG
    Clin Pharmacol Ther; 1983 Dec; 34(6):799-804. PubMed ID: 6641096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of enprofylline in healthy elderly subjects.
    Lunell E; Borgå O
    Eur J Clin Pharmacol; 1987; 32(1):67-70. PubMed ID: 3582470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance and some circulatory effects of intravenous and oral enprofylline in healthy volunteers.
    Lunell E; Andersson KE; Persson CG
    Acta Pharmacol Toxicol (Copenh); 1983 Sep; 53(3):205-11. PubMed ID: 6637510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single- and multiple-dose pharmacokinetics, kidney tolerability and plasma protein binding of tenoxicam in renally impaired patients and healthy volunteers.
    Nilsen OG; Aasarød K; Widerøe TE; Guentert TW
    Pharmacol Toxicol; 2001 Nov; 89(5):265-72. PubMed ID: 11881981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age on the disposition and renal handling of enprofylline in rats.
    Muraoka I; Hasegawa T; Nadai M; Wang L; Tagaya O; Nabeshima T
    J Pharm Pharmacol; 1994 Mar; 46(3):230-4. PubMed ID: 8027934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enprofylline pharmacokinetics in children with asthma.
    Hultqvist C; Borgå O
    Eur J Clin Pharmacol; 1987; 32(5):533-5. PubMed ID: 3622600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment.
    Patel IH; Sugihara JG; Weinfeld RE; Wong EG; Siemsen AW; Berman SJ
    Antimicrob Agents Chemother; 1984 Apr; 25(4):438-42. PubMed ID: 6329080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship.
    Kleinbloesem CH; van Brummelen P; van Harten J; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1985 May; 37(5):563-74. PubMed ID: 3987180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Additive bronchodilator effects of terbutaline and enprofylline in asthma.
    Rasmussen JB; Lunell E
    Eur J Clin Pharmacol; 1987; 32(1):23-6. PubMed ID: 3582466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ampicillin on the elimination of enprofylline in man.
    Paulsen O; Borgå O; Andersson KE
    Pharmacol Toxicol; 1987 May; 60(5):380-4. PubMed ID: 3615348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of carteolol in relation to renal function.
    Hasenfuss G; Schäfer-Korting M; Knauf H; Mutschler E; Just H
    Eur J Clin Pharmacol; 1985; 29(4):461-5. PubMed ID: 4092726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of enprofylline to asthmatic patients.
    Laursen LC; Johannesson N; Fagerström PO; Weeke B
    Eur J Clin Pharmacol; 1983; 24(3):323-7. PubMed ID: 6345176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefoxitin in patients with normal or impaired renal function.
    Garcia MJ; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Eur J Clin Pharmacol; 1979 Sep; 16(2):119-24. PubMed ID: 499308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enprofylline: pharmacokinetics and comparison with theophylline of acute effects on bronchial reactivity in normal subjects.
    Kluge TB; Oellerich M; Schumann G; Sybrecht GW
    Eur J Clin Pharmacol; 1986; 30(1):21-5. PubMed ID: 3709629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in renal uptake kinetics of the xanthine derivative enprofylline in endotoxaemic mice.
    Nadai M; Hasegawa T; Wang L; Haghgoo S; Okasaka T; Nabeshima T; Kato N
    J Pharm Pharmacol; 1996 Jul; 48(7):744-8. PubMed ID: 8866341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probenecid on enprofylline kinetics in man.
    Borgå O; Larsson R; Lunell E
    Eur J Clin Pharmacol; 1986; 30(2):221-3. PubMed ID: 3709650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal.
    Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A
    Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cefepime in subjects with renal insufficiency.
    Barbhaiya RH; Knupp CA; Forgue ST; Matzke GR; Guay DR; Pittman KA
    Clin Pharmacol Ther; 1990 Sep; 48(3):268-76. PubMed ID: 2401125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.